George C. K. Liu, MD, PhD
President & CEO
Dr. George Liu serves as the President, CEO, and CMO of the Chinese-American IPA Inc., d/b/a Coalition of Asian- American IPA (CAIPA), and as Chairman of the Asian-American Accountable Care Organization (AAACO) boards. As an internist and endocrinologist, Dr. Liu has been continuously providing quality care to his patients and contributing to the well-being of the Asian-American communities he has been serving since 1985. In addition to his private practices, he has been an attending physician at various hospitals, such as New York-Presbyterian Lower Manhattan Hospital, Mount Sinai Beth Israel, and NYU Langone Medical Center.
Dr. Liu graduated with a Ph.D. degree from the University of Notre Dame in 1972 and he went to The Rockefeller University as the Biochemist in the Center of Prevention of Premature Atherosclerosis and research on Cholesterol Metabolism as guest Investigator and subsequently as Assistant Professor. He received his medical degree in 1978 from Weill Cornell Medicine and completed his internship and residency in 1981 at NYU Medical Center—Manhattan Veteran Administration Hospital. After his residency, Dr. Liu completed his fellowship in endocrinology in 1983 at Stanford University Medical Center. At the same time, he also worked as Clinical Associate Physician at the General Clinical Research Center at Stanford, conducted research on Diabetes and Insulin resistance with Dr. Gerald Reaven who discovered the Metabolic Syndrome X.
Dr. Liu has received numerous distinctions and honors, including an award from the American Diabetes Association. Top Doctors: New York Metro Area” list by Castle Connolly every year for the last 15 years, and the “Best Doctor” by New York Magazine. Dr. Liu is also recognized and received multiple citations from New York State Assembly, New York City Council, and Commendation from City of New York Office of the Controller. Over the years, he has had various research articles published in collaboration with other distinguished physicians.
In 1994, Dr. Liu united a group of downtown community physicians and founded the Chinese Physician Partnership (CPP). In 1998, CPP gained the NYS Department of Health and Insurance’s consent to restructure as an Independent Practice Association and was renamed Chinese American IPA (CAIPA). Since then, CAIPA has flourished into a strong organization with nearly 1,100 members and affiliates serving over 500,000 Asian-American residents in Greater New York. In addition, CAIPA sponsors the CAMS-CAIPA Community Service Fund to encourage the development and improvement of existing, culturally competent, community-oriented service programs, as well as research and educational projects that benefit the Asian-American communities of New York. He is also on the board of the CAIPA Foundation Inc., a not-for-profit organization that is funded by donations from physicians-members.
Under Dr. Liu’s leadership, CAIPA is regarded as a model IPA by its peers and New York health plans by providing culturally sensitive, cost-effective, and high-quality care to the Asian-American communities. In line with his vision of further lowering healthcare costs and improving the overall quality of patient care, CAIPA has endorsed the formation of the Asian-American Accountable Care Organization (AAACO), which the Centers for Medicare and Medicaid Services awarded an ACO-Medicare contract in 2013.
Dr. Liu founded the Asian Diabetes Center in March 2011 to improve the quality of diabetic care for the Asian-American community. Diabetes has become a prevalent health problem in Asian-Americans. The clinic in Manhattan’s Chinatown provides comprehensive care and education services to assist the community to prevent or better manage diabetes. Dr. Liu wants to ensure that patients are receiving a comprehensive team approach in combating diabetes. The diabetes care team includes specialists in Endocrinology, Cardiology, Podiatry, Ophthalmology, Vascular Surgery, Nephrology, Diabetic Educator and Nutritionist. Throughout the years, the Center is able to improve most difficult managed patients referred from the community practitioners to the Center.
|Specialty||President & CEO|